BenevolentAI: against COVID-19
Entity: BenevolentAI Category: AI for Drug Discovery Description: BenevolentAI is a developer of artificial intelligence and computational medicine technologies. 1. Project: COGENT (COvid-19 Genomic Evaluation of Novel Therapies). Research Group: With the Cardiovascular Epidemiology Unit at Cambridge. Summary: The COGENT (COvid-19 Genomic Evaluation of Novel Therapies) portfolio o...
AI for Drug Discovery
Technology
1905
Founded
51-100
Employees
N/A
Industry
Visual (Placeholder)
Profile Information
Name
BenevolentAI: against COVID-19
Industry
N/A
Technology
AI for Drug Discovery
Location
United Kingdom
Founded
1905
Employees
51-100
Category
Company